Comparative analysis of different stroke subtype burden and future trends over 15 years in China and globally from 1990 to 2021

1990年至2021年中国及全球不同卒中亚型负担及未来趋势的比较分析

阅读:1

Abstract

OBJECTIVE: This study aimed to characterize the temporal trends in the burden of various stroke subtypes, including incidence, prevalence, mortality, and disability-adjusted life years (DALYs), across different age and sex groups in China from 1990 to 2021 and compare these trends with global data. METHODS: This study utilizes data from the Global Burden of Disease (GBD) 2021 public dataset to examine temporal trends in different stroke subtypes over the past three decades, both globally and in China. Joinpoint regression and autoregressive integrated moving average (ARIMA) models were applied to analyze historical patterns and forecast future trajectories. RESULTS: The age-standardized incidence rate (ASIR) and the age-standardized prevalence rate (ASPR) exhibited similar trends, with ischemic stroke (IS) showing an increase, while intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) displayed a decline. The ASIR of IS in China increased from 100.049 to 135.789 per 100,000. In contrast, the ASIR for ICH decreased from 108.931 to 61.153 per 100,000, and the ASIR for SAH declined from 17.957 to 7.811 per 100,000. In terms of mortality and DLAYs, the age-standardized mortality rate (ASMR) and the age-standardized DALYs (ASDR) for IS, ICH, and SAH all declined. Globally, stroke burden decreased for all subtypes, with men generally more affected than women. The highest burden remains in older populations. Projections suggest a continued rise in IS and ICH prevalence, but a stable trend for SAH. CONCLUSION: In China, although the burden of most stroke subtypes has declined, IS and ICH still require sustained prevention and management efforts, particularly in light of their rising prevalence among men and the older adult.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。